- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04118465
Prospective Randomized Controlled Trial Comparing ECV Success Rates With and Without Full Urinary Bladder (ECVBLADDER)
February 9, 2021 updated by: Ezra Yosi, Hadassah Medical Organization
A comparison of external cephalic (ECV) success rates when ECV performed with full urinary bladder or not.
The study is prospective and randomised.
Both nulliparous and multiparous women will be enrolled in the study, however each group will be randomized separately either to full urinary bladder or not.
Written informed consent will be obtained prior to inclusion in the study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A comparison of external cephalic (ECV) success rates when ECV performed with full urinary bladder or not.
The study is prospective and randomised.
Both nulliparous and multiparous women will be enrolled in the study, however each group will be randomized separately either to full urinary bladder or not.
Written informed consent will be obtained prior to inclusion in the study.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jerusalem, Israel, 91120
- Hadassah Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- non-cephalic presentation,
- singleton pregnancy,
- term gestation,
- No previous attempt at ECV in this pregnancy,
- signed informed consent.
Exclusion Criteria:
• Any contraindication for vaginal delivery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: ECV with Full urinary bladder
|
external cephalic version
|
Active Comparator: ECV with empty urinary bladder
|
external cephalic version
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ECV success rate
Time Frame: immediate
|
ECV success rate
|
immediate
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2002
Primary Completion (Actual)
December 31, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
October 5, 2019
First Submitted That Met QC Criteria
October 5, 2019
First Posted (Actual)
October 8, 2019
Study Record Updates
Last Update Posted (Actual)
February 10, 2021
Last Update Submitted That Met QC Criteria
February 9, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ECVBLAD-HMO-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
After study completion and publishing
IPD Sharing Access Criteria
IPD will be supplied to interested research colleagues.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breech Presentation; Before Labor
-
Herning HospitalCompletedPresentation; Breech, With External Version Before Labor
-
Region SkaneSuspended
-
Chelsea and Westminster NHS Foundation TrustUnknownPresentation; Breech, Complicating PregnancyUnited Kingdom
-
G. d'Annunzio UniversityNot yet recruiting
-
Nantes University HospitalCompletedBreech Presentation in PregnancyFrance
-
Johann Wolfgang Goethe University HospitalUnknown
-
Rambam Health Care CampusRecruitingBreech Presentation of Fetus With Successful VersionIsrael
-
Hadassah Medical OrganizationUnknown
-
University Hospital, GrenobleCompletedBreech Fetal PresentationFrance
-
McMaster UniversityUniversity of British Columbia; Canadian Institutes of Health Research (CIHR)Completed
Clinical Trials on external cephalic version
-
Shaare Zedek Medical CenterRecruitingTwin Pregnancy With Antenatal ProblemIsrael
-
Charite University, Berlin, GermanyRecruitingBreech Presentation | Twin; Complicating PregnancyGermany
-
The University of Hong KongNot yet recruitingMalpresentation Before Labor Affecting Fetus or Newborn
-
McMaster UniversityUniversity of British Columbia; Canadian Institutes of Health Research (CIHR)Completed
-
SandozHexal AGCompletedChronic Kidney DiseasePoland, Germany, Romania, Italy, Austria, Bulgaria, France, Macedonia, The Former Yugoslav Republic of, Russian Federation, Ukraine
-
Hadassah Medical OrganizationTerminatedBreech PresentationIsrael
-
PfizerCompletedHealthy VolunteersUnited States
-
University Hospital of PatrasCompletedPacemaker | Implantable Cardioverter-defibrillatorGreece
-
Hospices Civils de LyonCompletedPacemaker | Implantable Cardioverter-defibrillatorFrance